CIK 0001856725 · <br>Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 863114789
- Phone
- (408) 457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-16 | BUTEL JEAN LUC Director | Grant or award · Stock Option (Right to Buy) | +18,875 | 18,875 | ||
| 2023-12-16 | Nanavaty Maulik Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | Nanavaty Maulik Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | Nanavaty Maulik Director | Returned to the company · Stock Option (Right to Buy) | −15,423 | 63,894 | ||
| 2023-12-16 | Nanavaty Maulik Director | Grant or award · Stock Option (Right to Buy) | +15,423 | 15,423 | ||
| 2023-12-16 | Farquharson Andrew Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | Farquharson Andrew Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | Rometty Lisa Ann Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-16 | Rometty Lisa Ann Director | Returned to the company · Stock Option (Right to Buy) | −17,708 | 31,329 | ||
| 2023-12-16 | Rometty Lisa Ann Director | Grant or award · Stock Option (Right to Buy) | +17,708 | 17,708 | ||
| 2023-12-16 | IMRAN MIR A Director | Returned to the company · Stock Option (Right to Buy) | −101,276 | 0 | ||
| 2023-12-16 | IMRAN MIR A Director | Grant or award · Stock Option (Right to Buy) | +101,276 | 101,276 | ||
| 2023-12-06 | Imran Talat Chief Executive Officer | Purchase | +10,000 | $2.27 | $23K | 484,455 |
| 2023-12-04 | Imran Talat Chief Executive Officer | Purchase | +5,000 | $2.57 | $13K | 474,455 |
| 2023-11-29 | Imran Talat Chief Executive Officer | Purchase | +20,000 | $2.05 | $41K | 469,455 |
| 2023-11-24 | Quiroga Cortes Isidoro Alfonso 10% owner | Sale | −5,265,165 | $2.01 | $10.6M | 8,400 |
| 2023-11-24 | South Cone Investments Limited Partnership 10% owner | Purchase | +5,265,165 | $2.01 | $10.6M | 12,131,554 |
| 2023-11-17 | BUTEL JEAN LUC Director | Purchase | +50,500 | $2.03 | $102K | 50,500 |
| 2023-11-16 | Nanavaty Maulik Director | Purchase | +500 | $1.98 | $990 | 500 |
Page 7 of 9 · 178 trades